These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27683753)

  • 21. Human differentiated eosinophils release IL-13 in response to IL-33 stimulation.
    Uchida AM; Ro G; Qiang L; Peterson KA; Round J; Dougan M; Dougan SK
    Front Immunol; 2022; 13():946643. PubMed ID: 36177009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the secondary granule proteins major basic protein 1 (MBP-1) and eosinophil peroxidase (EPX) is required for eosinophilopoiesis in mice.
    Doyle AD; Jacobsen EA; Ochkur SI; McGarry MP; Shim KG; Nguyen DT; Protheroe C; Colbert D; Kloeber J; Neely J; Shim KP; Dyer KD; Rosenberg HF; Lee JJ; Lee NA
    Blood; 2013 Aug; 122(5):781-90. PubMed ID: 23736699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell response.
    Kawauchi T; Ishimaru K; Nakamura Y; Nakano N; Hara M; Ogawa H; Okumura K; Shibata S; Nakao A
    Allergol Int; 2017 Jul; 66(3):472-478. PubMed ID: 28259547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils.
    Cherry WB; Yoon J; Bartemes KR; Iijima K; Kita H
    J Allergy Clin Immunol; 2008 Jun; 121(6):1484-90. PubMed ID: 18539196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of eosinophil lineage-committed progenitors in the murine bone marrow.
    Iwasaki H; Mizuno S; Mayfield R; Shigematsu H; Arinobu Y; Seed B; Gurish MF; Takatsu K; Akashi K
    J Exp Med; 2005 Jun; 201(12):1891-7. PubMed ID: 15955840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous interleukin-17A inhibits eosinophil differentiation and alleviates allergic airway inflammation.
    Tian BP; Hua W; Xia LX; Jin Y; Lan F; Lee JJ; Lee NA; Li W; Ying SM; Chen ZH; Shen HH
    Am J Respir Cell Mol Biol; 2015 Apr; 52(4):459-70. PubMed ID: 25180833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-33 exacerbates eosinophil-mediated airway inflammation.
    Stolarski B; Kurowska-Stolarska M; Kewin P; Xu D; Liew FY
    J Immunol; 2010 Sep; 185(6):3472-80. PubMed ID: 20693421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation.
    Shik D; Moshkovits I; Karo-Atar D; Reichman H; Munitz A
    Allergy; 2014 Jun; 69(6):719-29. PubMed ID: 24735452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of interleukin-5 receptor-alpha short hairpin RNA-expressing vector on bone marrow eosinophilopoiesis in asthmatic mice.
    Mao H; Wen FQ; Liu CT; Liang ZA; Wang ZL; Yin KS
    Adv Ther; 2006; 23(6):938-56. PubMed ID: 17276963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lyn tyrosine kinase is important for IL-5-stimulated eosinophil differentiation.
    Stafford S; Lowell C; Sur S; Alam R
    J Immunol; 2002 Feb; 168(4):1978-83. PubMed ID: 11823534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-33/ST2 signaling modulates Afghanistan particulate matter induced airway hyperresponsiveness in mice.
    Berman R; Kopf KW; Min E; Huang J; Downey GP; Alam R; Chu HW; Day BJ
    Toxicol Appl Pharmacol; 2020 Oct; 404():115186. PubMed ID: 32777237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The IL-33/ST2 pathway is not essential to Th2 stimulation but is key for modulation and survival during chronic infection with Schistosoma mansoni in mice.
    Maggi L; Rocha IC; Camelo GMA; Fernandes VR; Negrão-Corrêa D
    Cytokine; 2021 Feb; 138():155390. PubMed ID: 33341001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non-asthmatic volunteers.
    Menzies-Gow AN; Flood-Page PT; Robinson DS; Kay AB
    Clin Exp Allergy; 2007 Jul; 37(7):1023-32. PubMed ID: 17581195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ATG5 promotes eosinopoiesis but inhibits eosinophil effector functions.
    Germic N; Hosseini A; Stojkov D; Oberson K; Claus M; Benarafa C; Calzavarini S; Angelillo-Scherrer A; Arnold IC; Müller A; Riether C; Yousefi S; Simon HU
    Blood; 2021 May; 137(21):2958-2969. PubMed ID: 33598715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trib1 regulates eosinophil lineage commitment and identity by restraining the neutrophil program.
    Mack EA; Stein SJ; Rome KS; Xu L; Wertheim GB; Melo RCN; Pear WS
    Blood; 2019 May; 133(22):2413-2426. PubMed ID: 30917956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-33 receptor (ST2) deficiency downregulates myeloid precursors, inflammatory NK and dendritic cells in early phase of sepsis.
    Babic ZM; Zunic FZ; Pantic JM; Radosavljevic GD; Jovanovic IP; Arsenijevic NN; Lukic ML
    J Biomed Sci; 2018 Jul; 25(1):56. PubMed ID: 30001716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficiency in IL-33/ST2 Axis Reshapes Mitochondrial Metabolism in Lipopolysaccharide-Stimulated Macrophages.
    Xu H; Sun L; He Y; Yuan X; Niu J; Su J; Li D
    Front Immunol; 2019; 10():127. PubMed ID: 30774633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The membrane-associated ubiquitin ligases MARCH2 and MARCH3 target IL-5 receptor alpha to negatively regulate eosinophilic airway inflammation.
    Zeng LW; Feng L; Liu R; Lin H; Shu HB; Li S
    Cell Mol Immunol; 2022 Oct; 19(10):1117-1129. PubMed ID: 35982175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-12 inhibits eosinophil differentiation from bone marrow stem cells in an interferon-gamma-dependent manner in a mouse model of asthma.
    Rais M; Wild JS; Choudhury BK; Alam R; Stafford S; Dharajiya N; Sur S
    Clin Exp Allergy; 2002 Apr; 32(4):627-32. PubMed ID: 11972612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses.
    Topczewska PM; Rompe ZA; Jakob MO; Stamm A; Leclère PS; Preußer A; Duerr CU; Thole LML; Kotsch K; Artis D; Klose CSN
    Front Immunol; 2023; 14():1130933. PubMed ID: 37063913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.